[go: up one dir, main page]

IT201600083859A1 - Immunosage for the identification of antibodies against the Polioma JC virus (JCPyV) through the use of synthetic peptides. - Google Patents

Immunosage for the identification of antibodies against the Polioma JC virus (JCPyV) through the use of synthetic peptides.

Info

Publication number
IT201600083859A1
IT201600083859A1 IT102016000083859A IT201600083859A IT201600083859A1 IT 201600083859 A1 IT201600083859 A1 IT 201600083859A1 IT 102016000083859 A IT102016000083859 A IT 102016000083859A IT 201600083859 A IT201600083859 A IT 201600083859A IT 201600083859 A1 IT201600083859 A1 IT 201600083859A1
Authority
IT
Italy
Prior art keywords
immunosage
jcpyv
polioma
virus
identification
Prior art date
Application number
IT102016000083859A
Other languages
Italian (it)
Inventor
Fernanda Martini
Mauro Tognon
Elisa Mazzoni
Ilaria Bononi
Silvia Pietrobon
Original Assignee
Univ Degli Studi Di Ferrara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Di Ferrara filed Critical Univ Degli Studi Di Ferrara
Priority to IT102016000083859A priority Critical patent/IT201600083859A1/en
Publication of IT201600083859A1 publication Critical patent/IT201600083859A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/22011Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01DNA viruses
    • G01N2333/025Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
IT102016000083859A 2016-08-09 2016-08-09 Immunosage for the identification of antibodies against the Polioma JC virus (JCPyV) through the use of synthetic peptides. IT201600083859A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102016000083859A IT201600083859A1 (en) 2016-08-09 2016-08-09 Immunosage for the identification of antibodies against the Polioma JC virus (JCPyV) through the use of synthetic peptides.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000083859A IT201600083859A1 (en) 2016-08-09 2016-08-09 Immunosage for the identification of antibodies against the Polioma JC virus (JCPyV) through the use of synthetic peptides.

Publications (1)

Publication Number Publication Date
IT201600083859A1 true IT201600083859A1 (en) 2018-02-09

Family

ID=58606305

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102016000083859A IT201600083859A1 (en) 2016-08-09 2016-08-09 Immunosage for the identification of antibodies against the Polioma JC virus (JCPyV) through the use of synthetic peptides.

Country Status (1)

Country Link
IT (1) IT201600083859A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0967397A (en) * 1995-06-23 1997-03-11 Eisai Co Ltd Anti-jc virus antibody
WO2011085369A1 (en) * 2010-01-11 2011-07-14 Biogen Idec Ma Inc. Assay for jc virus antibodies
WO2013014134A2 (en) * 2011-07-22 2013-01-31 Universitätsklinikum Hamburg-Eppendorf Polyoma virus jc peptides and proteins in vaccination and diagnostic applications

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0967397A (en) * 1995-06-23 1997-03-11 Eisai Co Ltd Anti-jc virus antibody
WO2011085369A1 (en) * 2010-01-11 2011-07-14 Biogen Idec Ma Inc. Assay for jc virus antibodies
WO2013014134A2 (en) * 2011-07-22 2013-01-31 Universitätsklinikum Hamburg-Eppendorf Polyoma virus jc peptides and proteins in vaccination and diagnostic applications

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "JC polyomavirus (JCPyV) VP-1 - Protein - UniProt/Swiss-Prot Q82943", 31 October 2006 (2006-10-31), XP055376682, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/protein/Q82943> [retrieved on 20170529] *
ANONYMOUS: "Stratify JCV Dx Select infosheet", 18 January 2013 (2013-01-18), pages 1 - 15, XP055376892, Retrieved from the Internet <URL:http://www.focusdx.com/pdfs/pi/US/EL1950.pdf> [retrieved on 20170530] *
D. E. ROLLISON ET AL: "Prospective Study of JC Virus Seroreactivity and the Development of Colorectal Cancers and Adenomas", CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION., vol. 18, no. 5, 21 April 2009 (2009-04-21), US, pages 1515 - 1523, XP055376960, ISSN: 1055-9965, DOI: 10.1158/1055-9965.EPI-08-1119 *
MARTYN K. WHITE ET AL: "Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy", REVIEWS IN MEDICAL VIROLOGY, vol. 26, no. 2, 14 December 2015 (2015-12-14), GB, pages 102 - 114, XP055327678, ISSN: 1052-9276, DOI: 10.1002/rmv.1866 *
NAOTO AOKI ET AL: "Antibody against synthetic multiple antigen peptides (MAP) of JC virus capsid protein (VP1) without cross reaction to BK virus: a diagnostic tool for progressive multifocal leukoencephalopathy", NEUROSCIENCE LETTERS, vol. 205, no. 2, 1 February 1996 (1996-02-01), AMSTERDAM, NL, pages 111 - 114, XP055376554, ISSN: 0304-3940, DOI: 10.1016/0304-3940(96)12389-2 *
PIOTR KARDAS ET AL: "Optimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling", JOURNAL OF CLINICAL VIROLOGY, vol. 71, 1 October 2015 (2015-10-01), NL, pages 28 - 33, XP055376469, ISSN: 1386-6532, DOI: 10.1016/j.jcv.2015.07.305 *

Similar Documents

Publication Publication Date Title
IL290842A (en) Anti-cd73 antibodies and uses thereof
IL279876A (en) Improved bi-spectral detector
EP3857419C0 (en) RANSOMWARE DETECTION
EP3822289A4 (en) ANTIBODY ANTI-SIRP ALPHA
IL262726A (en) Antibodies recognizing tau
DK3964529T3 (en) NON-BLOCKING PD1-SPECIFIC ANTIBODIES
HUE056677T2 (en) Anti-tim-3 antibodies and preparations
HUE053737T2 (en) Pyridopyrroloquinoxaline compounds, their preparations and their uses
IT201700070755A1 (en) &#34;SEPARATION SYSTEM&#34;
PL3362477T3 (en) ANTIGEN BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECIPE
CL2018001139A1 (en) Anti-htra1 antibodies and methods of use thereof.
FR3033018B1 (en) TUBULAR ELEMENT SUPPORT PART, IN PARTICULAR FOR AN AIRCRAFT.
EP3692072A4 (en) ANTI-HLA-DQ2.5 ANTIBODIES
EP3700558A4 (en) TAU PEPTIDE IMMUNOGEN CONSTRUCTS
DK3464331T3 (en) STABILIZED PREFUSION RSV F PROTEINS
IL281717A (en) Antibody formulation
EP3427023A4 (en) HYPERSPECTRAL IMAGING ARRANGEMENT
IL258924A (en) Humanized anti-Dicoff-related protein 2 antibody and uses thereof
IL281594A (en) Antibodies against KLRG1
DK3448879T3 (en) CLAUDIN-6 PEPTIDES
IL268600A (en) A method for determining the potency of adeno-associated virus preparations
EP3465249A4 (en) MULTIPIXEL SCANING LIDAR
DK3452515T3 (en) HER-2-BINDING ANTIBODIES
DK3484921T3 (en) Anti-IL-22R antibodies
ITUA20161865A1 (en) Use of lentinan for the treatment and prevention of endometriosis.